Document control
Specifications, procedures, records and approved changes must be current, traceable and available to the people responsible for execution and review.
Quality & Pharmaceutical Responsibility
Quality Is a System of Decisions, Not a Final Inspection.
Jean Vichar approaches quality as a continuous framework connecting technical assessment, materials, processes, documentation, manufacturing and lifecycle improvement.
REF. JV-QUAL-001QUALITY PHILOSOPHY
Quality begins before production and continues after release.
A dependable pharmaceutical product is the result of controlled inputs, understood processes, documented decisions and accountable review at every stage.
Jean Vichar’s quality philosophy is based on Good Manufacturing Practice principles and on the understanding that quality cannot be added at the end of a process. It must be considered when a product is first assessed, when materials and suppliers are selected, when a process is transferred or scaled, and when commercial manufacturing is performed.
Our quality approach is intended to protect product consistency, patient safety and partner confidence. The precise quality plan for each program depends on the dosage form, project stage, regulatory pathway, source documentation and responsibilities agreed with the partner.
REF. JV-QMS-002QUALITY SYSTEM
Core controls that support reliable pharmaceutical operations.
The following principles describe the operating framework. Product-specific controls are defined within approved project and quality documentation.
Materials and suppliers
APIs, excipients, components and packaging materials require defined specifications, appropriate qualification and documented receipt and handling.
Training and responsibility
Personnel should understand the procedures they perform, the records they create and the impact their work has on product quality.
Process control
Manufacturing steps, in-process checks, critical parameters and acceptance criteria are established according to the product and process.
Deviation and change management
Unexpected events and proposed changes require documented assessment, investigation, approval and follow-up proportionate to risk.
Review and improvement
Quality data, manufacturing experience and partner feedback are used to identify recurring issues and strengthen future performance.
REF. JV-VALID-003VALIDATION & TECHNOLOGY TRANSFER
Knowledge transfer
A successful transfer begins with complete technical information: formulation history, process description, material specifications, analytical methods, device or packaging requirements and known product risks.
Scale-up planning
Laboratory or source-site processes are evaluated against available equipment, operating ranges, material behavior and the controls required at the intended manufacturing scale.
Qualification and validation
Equipment, utilities, methods, cleaning and manufacturing processes are addressed through the applicable qualification or validation activities defined for the program.
Continued verification
Commercial experience should be reviewed to confirm the process remains controlled and to identify opportunities for corrective action or improvement.
Defined responsibilitiesQuality agreements and project plans clarify who owns each activity, record and decision.
Traceable documentationTechnical and manufacturing records should support review, investigation and regulatory use.
Risk-based attentionControls are focused where material, process or product risks can affect quality and performance.
REF. JV-PARTNER-004PARTNER QUALITY
Quality works best when both sides communicate early and clearly.
CMO and CDMO programs depend on an effective quality relationship between the product owner and the manufacturing organization.
Before work begins, Jean Vichar seeks to understand the partner’s product knowledge, dossier status, specifications, analytical requirements, change history, supply expectations and market obligations. Open issues should be identified before they become manufacturing delays or quality events.
Throughout the program, technical and quality teams coordinate on documentation, deviations, changes, validation activities, batch review and continuing supply. This collaboration is especially important for technology-transfer projects, respiratory products and programs involving specialized components or devices.
REF. JV-FAQ-005QUALITY QUESTIONS
Does Jean Vichar work according to GMP principles?
Jean Vichar’s published company principles include manufacturing under Good Manufacturing Practice principles. The specific standards, approvals and documentation applicable to a project should be confirmed with the quality team during technical evaluation.
Can Jean Vichar support technology transfer and validation?
Yes. Technology transfer, scale-up and validation support can form part of a CMO or CDMO program, subject to product fit, available documentation, technical assessment and an agreed project scope.
How are quality responsibilities divided with a partner?
Responsibilities should be defined through the project plan, technical documents and, where appropriate, a quality agreement covering activities such as specifications, materials, testing, deviations, changes, batch documentation and release responsibilities.
Can certifications or site-specific approvals be provided?
Current certificates, licenses, inspection information and product-specific regulatory documentation should be requested directly from Jean Vichar so the most current approved records can be supplied.
Quality Requirements Are Project-Specific
Share the product, market and documentation requirements with our team.
We can review the quality and technical framework required for development, transfer or commercial manufacturing before defining the next steps.
Contact the Jean Vichar Team